Cargando…

Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity

Cell destruction results in plasma accumulation of cell-free DNA (cfDNA). Dynamic changes in circulating lymphocytes are features of COVID-19. We aimed to investigate if cfDNA level can serve in stratification of COVID-19 patients, and if cfDNA level is associated with alterations in lymphocyte subs...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammad, Reham, Eldosoky, Mona Abd EL Rahman, Fouad, Shaimaa Hani, Elgendy, Abdelaleem, Tawfeik, Amany M, Alboraie, Mohamed, Abdelmaksoud, Mariam Fathy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054149/
https://www.ncbi.nlm.nih.gov/pubmed/33646058
http://dx.doi.org/10.1177/1753425921995577
_version_ 1783680248419713024
author Hammad, Reham
Eldosoky, Mona Abd EL Rahman
Fouad, Shaimaa Hani
Elgendy, Abdelaleem
Tawfeik, Amany M
Alboraie, Mohamed
Abdelmaksoud, Mariam Fathy
author_facet Hammad, Reham
Eldosoky, Mona Abd EL Rahman
Fouad, Shaimaa Hani
Elgendy, Abdelaleem
Tawfeik, Amany M
Alboraie, Mohamed
Abdelmaksoud, Mariam Fathy
author_sort Hammad, Reham
collection PubMed
description Cell destruction results in plasma accumulation of cell-free DNA (cfDNA). Dynamic changes in circulating lymphocytes are features of COVID-19. We aimed to investigate if cfDNA level can serve in stratification of COVID-19 patients, and if cfDNA level is associated with alterations in lymphocyte subsets and neutrophil-to-lymphocyte ratio (NLR). This cross-sectional comparative study enrolled 64 SARS-CoV-2-positive patients. Patients were subdivided to severe and non-severe groups. Plasma cfDNA concentration was determined by real-time quantitative PCR. Lymphocyte subsets were assessed by flow cytometry. There was significant increase in cfDNA among severe cases when compared with non-severe cases. cfDNA showed positive correlation with NLR and inverse correlation with T cell percentage. cfDNA positively correlated with ferritin and C-reactive protein. The output data of performed ROC curves to differentiate severe from non-severe cases revealed that cfDNA at cut-off ≥17.31 ng/µl and AUC of 0.96 yielded (93%) sensitivity and (73%) specificity. In summary, excessive release of cfDNA can serve as sensitive COVID-19 severity predictor. There is an association between cfDNA up-regulation and NLR up-regulation and T cell percentage down-regulation. cfDNA level can be used in stratification and personalized monitoring strategies in COVID-19 patients.
format Online
Article
Text
id pubmed-8054149
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-80541492021-05-03 Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity Hammad, Reham Eldosoky, Mona Abd EL Rahman Fouad, Shaimaa Hani Elgendy, Abdelaleem Tawfeik, Amany M Alboraie, Mohamed Abdelmaksoud, Mariam Fathy Innate Immun Original Articles Cell destruction results in plasma accumulation of cell-free DNA (cfDNA). Dynamic changes in circulating lymphocytes are features of COVID-19. We aimed to investigate if cfDNA level can serve in stratification of COVID-19 patients, and if cfDNA level is associated with alterations in lymphocyte subsets and neutrophil-to-lymphocyte ratio (NLR). This cross-sectional comparative study enrolled 64 SARS-CoV-2-positive patients. Patients were subdivided to severe and non-severe groups. Plasma cfDNA concentration was determined by real-time quantitative PCR. Lymphocyte subsets were assessed by flow cytometry. There was significant increase in cfDNA among severe cases when compared with non-severe cases. cfDNA showed positive correlation with NLR and inverse correlation with T cell percentage. cfDNA positively correlated with ferritin and C-reactive protein. The output data of performed ROC curves to differentiate severe from non-severe cases revealed that cfDNA at cut-off ≥17.31 ng/µl and AUC of 0.96 yielded (93%) sensitivity and (73%) specificity. In summary, excessive release of cfDNA can serve as sensitive COVID-19 severity predictor. There is an association between cfDNA up-regulation and NLR up-regulation and T cell percentage down-regulation. cfDNA level can be used in stratification and personalized monitoring strategies in COVID-19 patients. SAGE Publications 2021-03-01 2021-04 /pmc/articles/PMC8054149/ /pubmed/33646058 http://dx.doi.org/10.1177/1753425921995577 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Articles
Hammad, Reham
Eldosoky, Mona Abd EL Rahman
Fouad, Shaimaa Hani
Elgendy, Abdelaleem
Tawfeik, Amany M
Alboraie, Mohamed
Abdelmaksoud, Mariam Fathy
Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity
title Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity
title_full Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity
title_fullStr Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity
title_full_unstemmed Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity
title_short Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity
title_sort circulating cell-free dna, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of covid-19 severity
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054149/
https://www.ncbi.nlm.nih.gov/pubmed/33646058
http://dx.doi.org/10.1177/1753425921995577
work_keys_str_mv AT hammadreham circulatingcellfreednaperipherallymphocytesubsetsalterationsandneutrophillymphocyteratioinassessmentofcovid19severity
AT eldosokymonaabdelrahman circulatingcellfreednaperipherallymphocytesubsetsalterationsandneutrophillymphocyteratioinassessmentofcovid19severity
AT fouadshaimaahani circulatingcellfreednaperipherallymphocytesubsetsalterationsandneutrophillymphocyteratioinassessmentofcovid19severity
AT elgendyabdelaleem circulatingcellfreednaperipherallymphocytesubsetsalterationsandneutrophillymphocyteratioinassessmentofcovid19severity
AT tawfeikamanym circulatingcellfreednaperipherallymphocytesubsetsalterationsandneutrophillymphocyteratioinassessmentofcovid19severity
AT alboraiemohamed circulatingcellfreednaperipherallymphocytesubsetsalterationsandneutrophillymphocyteratioinassessmentofcovid19severity
AT abdelmaksoudmariamfathy circulatingcellfreednaperipherallymphocytesubsetsalterationsandneutrophillymphocyteratioinassessmentofcovid19severity